E-ISSN:2456-3110

Case Report

Vata Rakta

Journal of Ayurveda and Integrated Medical Sciences

2025 Volume 10 Number 2 FEBRUARY
Publisherwww.maharshicharaka.in

Ayurvedic modalities in the management of Vata Rakta w.s.r. to Gout: A Case Study

Yadav N1*, Panja S2, Chakrabarty N3, Bhaduri T4
DOI:10.21760/jaims.10.2.51

1* Neha Yadav, Post Graduate Scholar 2nd Year, Institute of Post Graduate Ayurvedic Education and Research at Shyamadas Vaidya Shastra Pith (SVSP), Kolkata, West Bengal, India.

2 Soumya Panja, Post Graduate Scholar 2nd Year, Institute of Post Graduate Ayurvedic Education and Research at Shyamadas Vaidya Shastra Pith (SVSP), Kolkata, West Bengal, India.

3 Nabanita Chakrabarty, Lecturer, Department of Kayachikitsa, Institute of Post Graduate Ayurvedic Education and Research at Shyamadas Vaidya Shastra Pith (SVSP), Kolkata, West Bengal, India.

4 Tapas Bhaduri, Reader and HOD, Department of Kayachikitsa, Institute of Post Graduate Ayurvedic Education and Research at Shyamadas Vaidya Shastra Pith (SVSP), Kolkata, West Bengal, India.

Aahar (good diet) and Vihar (proper lifestyle) are important factor in Ayurveda for prevention and management of diseases. Rapid modernization, changing environmental factors and lifestyle are causing adverse influence over our health. Occurrence of Vatarakta is one of the major consequences of this modification. It is a condition where both Vata and Rakta gets vitiated by their individual causes and manifests as a disease so it is called as Vatarakta, Vatasonita or Vatasrka. The sign and symptoms of Vatarakta can be clinically correlated with the disease gout in modern science. In this present case study, a 27 years old female patient visited Kayachikitsa OPD of I.P.G.A.E & R at SVSP, Kolkata, with pain in multiple joints and tingling sensation in great toe of right foot for past 3 months. She was treated with Shamana Ausadhi for a duration of 2 month. Pathya and Apathya were properly instructed. Observation and results were drawn on the basis of assessment criteria. Encouraging improvement was noted in both subjective and objective parameter.

Keywords: Vatarakta, Gout, Chopchini, Mahamanjisthadi Kashaya

Corresponding Author How to Cite this Article To Browse
Neha Yadav, Post Graduate Scholar 2nd Year, , Institute of Post Graduate Ayurvedic Education and Research at Shyamadas Vaidya Shastra Pith (SVSP), Kolkata, West Bengal, India.
Email: 		Yadav N, Panja S, Chakrabarty N, Bhaduri T, Ayurvedic modalities in the management of Vata Rakta w.s.r. to Gout: A Case Study. J Ayu Int Med Sci. 2025;10(2):351-358.
Available From
https://jaims.in/jaims/article/view/4062/

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2025-01-14 2025-01-27 2025-02-07 2025-02-17 2025-02-27
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nill Not required 11.35

© 2025by Yadav N, Panja S, Chakrabarty N, Bhaduri T and Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

J Ayu Int Med Sci 2025;10(2)351
Download PDFBack To ArticleIntroductionMethodsCase StudyResultsDiscussionConclusionReferences
Neha Y et al. Management of Vata Rakta w.s.r. to Gout

Introduction

Amalgamation of vitiated Vata and Rakta leads to manifestation of this disease hence the disease is known as Vatarakta. The disease Vatarakta is vividly described in all the three classics of Ayurveda (Brihatrayee). Repeated false dietetic and behavioural regimen (Aharaja and Viharaja Nidana) increases Vata Dosha which further vitiates Rakta Dhatu. The pathway of Vata Dosha is obstructed by Rakta Dhatu, with Sukshmatwa Guna of Vayu and Dravatwa Guna of Rakta, they pervade throughout the body. Due to this obstruction, Vata Dosha abnormally increases and produce the disease particularly at smaller joints called as Vatarakta characterised by pain, swelling, stiffness, discoloration over joints.[1]

In contemporary science we can clinically correlate the manifestations of this disease with gout. The prevalence of gout is approximately 1-2% worldwide, with a greater than 5:1 male preponderance.[2]

Gout has become progressively more common over recent years due to increased prevalence of metabolic syndrome. It is a metabolic disorder of purine metabolism. As a result, monosodium urate crystal gets deposited in different joints characterized by intermittent attacks of acute pain, swelling and inflammation. It results from an increased body pool of urate with hyperuricaemia[3] (>6.0mg/dl in females & > 7mg/dl in males). The risk of developing gout increases with age and with serum uric acid levels. Primarily middle-aged to elderly men and women are affected. Now a days, excessive high protein rich diet, sedentary lifestyle, intake of incompatible food, stress etc. has subsequently led to increase in prevalence of this disease.

Samprapti Ghatak:

Dosha - Vata Pradhan Tridosaja, Rakta
Vata - Vyana
Pitta - Pachak
Kapha - Shleshmaka
Dushya - Rasa, Rakta, Mamsa
Sroto Dushti - Sanga Paschat Vimargagaman
Agni - Mandagni
Utpatti Sthan - Pakwasaya
Adhisthana - Sandhi, Twaka, Mamsa
Swabhava - Chirakari

Types on the basis of

Dosha Bheda[4]:

1. Vatadhikya
2. Pittadhikya
3. Kaphadikhya
4. Raktadhikya
5. Dvandaja
6. Sannipatika

Sthana Bheda[5]:

1. Uttan vatarakta (Superficial) - When pathogenesis is limited to Twak and Mamsa Dhatu.
2. Gambhir Vatarakta (Deep seated) - Involvement of deeper Dhatu like Asthi, Sandhi, Majja.

Methods

A female patient came to Kayachikitsa OPD on complaining of pain in multiple joints associated with tingling sensation in great toe of right foot for past 3 months. On the basis of clinical signs and symptoms we diagnosed this case as Vatarakta. Treatment schedule was planned accordingly.

Case Study

A 27-year-old female came to Kayachikitsa OPD of I.P.G.A.E&R at SVSP, Kolkata with Chief complains-

  • Pain in multiple joints
  • Tingling sensation in great toe of right foot.

Associated complain:

  • Mild swelling in both ankle joint
  • B/L burning sensation in sole.
  • Duration - Past 3 months.

Aggravating factors:

  • Prolonged standing

Relieving factors - No Such
Mode of onset - Acute
Progress - Gradual
Past medical History - No such
Past Surgical History - No such
Family History - No such
Addiction - No such

Personal History:

Appetite - Diminished
Bowel - Constipated
Bladder - Normal


J Ayu Int Med Sci 2025;10(2)352
Neha Y et al. Management of Vata Rakta w.s.r. to Gout

Digestion - Irregular
Sleep - Adequate
Occupation - Housewife
Diet - Non vegetarian 

Ashtavidha Pariksha:

Nadi - Vata Pittaja
Mala - Baddha
Mutra - Svabhavik
Jihva - Isat Sama
Sabda - Sphastha
Sparsha - Ushna
Drik - Swabhavik
Akriti - Madhyama

General Examination: Patient was alert, cooperative and conscious.

BP - 124/82 mm of Hg
P. R - 76b/m
Resp. Rate - 14/min
Weight - 58 kg
Icterus - Absent
Cyanosis - Absent
Pallor - Absent
Oedema - B/L mild pitting oedema in both ankle joint.
Clubbing - Absent
Lymphadenopathy - Absent

Objective: To study the efficacy of Shamana Auosadhi in the management of Vatarakta.

Diagnostic Assessment: On the basis of clinical sign and symptoms we diagnosed the case as Vatarakta.

Subjective Parameter: Showing gradation of symptoms according to WHO scoring pattern[6]

Symptoms

Swelling:

Grade 0 - No swelling 
Grade 1 - Slight swelling  
Grade 2 - Moderate swelling  
Grade 3 - Severe swelling

Discoloration:

Grade 0 - Normal coloration 
Grade 1 - Near to normal which looks like normal to distant observer. 
Grade 2 - Reddish discoloration
Grade 3 - Slightly reddish black discoloration 

Grade 4 - Blackish discoloration

Burning sensation:

Grade 0 - No burning sensation
Grade 1 - Mild burning sensation 
Grade 2 - Moderate burning sensation
Grade 3 - Severe burning sensation

Pain:

Grade 0 - No pain 
Grade 1 - Mild pain
Grade 2 - Moderate pain but no difficulty in moving. 
Grade 3 - Slightly difficulty in moving due to pain. 
Grade 4 - Much difficulty

Objective parameter: The assessment criteria were serum uric acid (more than 7mg/dl in males and 6mg/dl in females respectively) before, mid and after treatment. Blood for FBS and PPBS was also done before treatment for differential diagnosis.

Treatment Plan: She was treated with Shamana Auosadhi for 3 months. Pathya and Apathya were properly instructed.

SNShamana auosadhiDose with Anupana
1.Mahamanjisthadi Kashaya15 ml twice daily with Sukosna Jala morning and evening empty stomach.
2.Kaisore Guggulu500 mg BDPC with Sukosna Jala twice daily after lunch and dinner
3.Pow Guduchi
  +
Pow Chopchini		3gm + 2gm with Madhu twice daily.
4.Pinda TailaLocal application

Pathya and Apathya[7-9]

Pathya Ahara:

Shúka Dhanya - Shashtika Shãli, Yava, Laja, Godhuma
Shami Dhanya - Mudga, Mãsha
Mãmsa Varga - Gramya Mãmsa, Jangala Mãmsa
Jala Varga - Ushna Jala
Ksheera Varg - Goksheera, Ajãkseera

Pathya Vihara: Abhyanga and Parishek etc.

Apathya Ahara: Katu, Ushna, Guru, Lavana, Madya, Dadhi, Kshara, Kuluttha, Amla, Pinyaka, Abhishyandi, Moolikãdi.

Apathya Vihara: Divã Swapna, Atapa Sevana, Ati Vyãyãma, Ati Maithuna etc.


J Ayu Int Med Sci 2025;10(2)353
Neha Y et al. Management of Vata Rakta w.s.r. to Gout

Results

The patient was treated at Outpatient department (OPD) with Shamana Auosadhi with dietary and lifestyle modification for a period of 2 months. Results were assessed on the basis of subjective and objective parameter. Encouraging improvement was noted in both subjective and objective parameter.

Changes in subjective parameters before, mid and after treatment.

SymptomsBefore treatmentMid treatmentAfter treatment.
Swelling in both ankle joint110
Discoloration000
Burning sensation310
Pain420

Changes in lab parameters (serum uric acid) before, mid and after treatment.
jaims_4062_01.jpg
Before Treatment

jaims_4062_02.jpg
Mid-Treatment


J Ayu Int Med Sci 2025;10(2)354
Neha Y et al. Management of Vata Rakta w.s.r. to Gout

jaims_4062_03.jpg
After Treatment

jaims_4062_04.jpg
Changes in blood investigation

jaims_4062_05.jpg
Graphical representation of observation


J Ayu Int Med Sci 2025;10(2)355
Neha Y et al. Management of Vata Rakta w.s.r. to Gout

DateSerum Uric Acid
22/10/247.3 mg/dl
26/11/245.60 mg/dl
26/12/245.40 mg/dl

Follow-up and Outcome:

The patient still comes to the OPD for further follow-up after every 15 days. She is treated with same Shamana Auosadhi. We get promising results till now. Below sharing her latest blood investigation report.

jaims_4062_06.jpg
Follow-up

DateSerum Uric acid (mg/dl)
29/01/20255.00 mg/dl

Probable mode of action of drugs

SNDravyaProbable mechanism of drug action
1.Mahamanjisthadi Kashay [10]Dahaprasaman, Kandughna, Varnya, Kusthanasak, Raktasodhak
2.Kaisore GugguluTridoshaghna, Rasayana
3.Pow GuduchiRasayana, Agnideepana, Tridosahara, Dahaprasamana
4.Pow ChopchiniVataroganam Vinasanam
5.Pinda TailaRujapaham

Discussion

Vatarakta is a Santarpana Janya Vyadhi where vitiated Vata and Rakta is simultaneously involved. It is a progressive disease. Firstly, it affects small joints thereafter gradually affect other joints too. It is categorised under Madhyam Rogamarga as Asthi, Sandhi is primarily involved in it.

Generally, it affects middle age groups who are prone to sedentary lifestyle and improper dietary regimen hence it is also known as Adhyavata. The main ingredient of Mahamanjisthadi Kashaya is Manjistha having potent Raktasodhak property. Majority of its drug is having Raktasodhak, Dahahara, Kandhughna, Varnya, Kusthanasak properties. Mahamanjisthadi Kashaya prevents ama formation by correcting Agni and promotes healthy blood circulation. The primary ingredient of Kaisore Guggulu[11-12] is Guduchi along with Dravyas like Triphala, Guggulu, Tryushana, Sunthi, Trivrita etc. Guduchi[13-14] is the drug of choice in Vatarakta. It has Raktasodhak, Rasayana, Vatahara and Dahaprasaman property (anti-inflammatory action). Guggulu has an excellent Balya, Rasayan, Varnya, Vatabalasjit property, being Tridosaghna in action it relieving from pain (analgesic) and inflammation (anti-inflammatory).[15] Tryaushana has Deepana, Amapachana, Anulomana property hence corrects the deranged Agni. Sunthi by its Deepana and Pachana property is Avaranahara and Raktasodhak. Trivritta performs Mrdu Virechan and eliminates the toxins from our body. Chopchini also known as Dwepantar Vacha[16] is a miraculous drug having Tridosha Shamak property. It has potent action over Vata Roga, Sandhishotha, Tvak Vikar etc. It possesses antioxidant, anti-inflammatory, anti-allergic properties.[17] Pinda Taila[18-20] with key ingredients like Manjistha, Sarjarasa, Sariva and Beewax on Sthanik Prayoga relieves from Ruja (pain). This Ayurvedic approach tackles the root cause of the disease exemplifying fundamental principles of Ayurveda.

Conclusion

The aim of present study is to analyze the role of Shaman Auosadhi in Vatarakta. Early diagnosis and treatment help in improving the quality of life. The present study has showed that Ayurvedic treatment modalities is highly effective in the management of Vatarakta (Gout) as evidenced by significant reduction in serum uric acid and improvement in both signs & symptoms without landing into further complication.

Acknowledgement

We would like to acknowledge the Apothecary department and Laboratory of I.P.G.A.E & R at SVSP, KOLKATA for providing all essential materials required during the study.


J Ayu Int Med Sci 2025;10(2)356
Neha Y et al. Management of Vata Rakta w.s.r. to Gout

Heartfelt gratitude to my seniors for their valuable suggestions and to everyone who have directly or indirectly guided me in writing this case study.

Declaration of Patient Consent

The authors certify that they have obtained all appropriate patient consent. She has given her consent for her clinical information to be reported in this journal. The patient was assured that her initials will not be published and due efforts will be made to conceal the identity.

References

1. Shastri K. Charak Samhita of Agnivesa, revised by Charaka and Drdhabala with Ayurveda-Dipika Commentary. Part 2. 2012 ed. Chaukambha Sanskrit Sansthan, Varanasi. Chikitsa Sthana 29/13-15. p. 731. ISBN: 978-81-89798-55-09 [Crossref][PubMed][Google Scholar]

2. Cluine GPR, Ralston SH. Rheumatology and Bone Diseases. In: Davidson's Principles and Practice of Medicine. 23rd ed. Ch. 24. p. 1012. ISBN: 978-0-7020-7028-0 [Crossref][PubMed][Google Scholar]

3. Schumacher HR, Chen LX. Gout and Other Crystal-Associated Arthropathies. In: Harrison’s Principles of Internal Medicine. Vol. 2. 18th ed. Ch. 333. p. 2837. ISBN: 978-0-07-174887-2; MHID: 0-07-174887-3 [Crossref][PubMed][Google Scholar]

4. Shastri K. Charak Samhita of Agnivesa, revised by Charaka and Drdhabala with Ayurveda-Dipika Commentary. Part 2. 2012 ed. Chaukambha Sanskrit Sansthan, Varanasi. Chikitsa Sthana 29/24. p. 750. ISBN: 978-81-89798-55-0 [Crossref][PubMed][Google Scholar]

5. Shastri K. Charak Samhita of Agnivesa, revised by Charaka and Drdhabala with Ayurveda-Dipika Commentary. Part 2. 2012 ed. Chaukambha Sanskrit Sansthan, Varanasi. Chikitsa Sthana 29/19. p. 749. ISBN: 978-81-89798-55-09 [Crossref][PubMed][Google Scholar]

6. Baghel MS, Rajagopala S. Developing Guidelines for Clinical Research Methodology in Ayurveda. WHO/TRM guidelines, 2000. Available from: [www. sho.int/entity/hiv/amds/WHOTCM2005.1 OMS.pdf]( OMS.pdf). Accessed 24 June 2006 [Article][Crossref][PubMed][Google Scholar]

7. Shastri AD. Bhaisajya Ratnavali Vidyotini Hindi Vyakhya. Chaukambha Orientalia, Varanasi. 2022 ed. Vata Rakta Chikitsa Prakaran 27/195-205. p. 811-812. ISBN: 978-93-86735-39-3 [Crossref][PubMed][Google Scholar]

8. Tewari P, Kumari A. Yogaratnakar Part 1. Chaukambha Visvabharati. 2010 ed. Vatarakta Ch. 26/95-102. p. 634. ISBN: 978-81-909871-7-2 [Crossref][PubMed][Google Scholar]

9. Shastri K. Charak Samhita of Agnivesa, revised by Charaka and Drdhabala with Ayurveda-Dipika Commentary. Part 2. 2012 ed. Chaukambha Sanskrit Sansthan, Varanasi. Chikitsa Sthana 29/45-50. p. 753. ISBN: 978-81-89798-55-09 [Crossref][PubMed][Google Scholar]

10. Tewari P, Kumari A. Yogaratnakar Part 1. Chaukambha Visvabharati. 2010 ed. Vatarakta Ch. 26/42-47. p. 634. ISBN: 978-81-909871-7-2 [Crossref][PubMed][Google Scholar]

11. Rao GP, editor. Chakradutta of Cakrapanidatta. Chaukambha Orientalia, Varanasi. 2014 ed. Ch. 42/44. p. 256. ISBN: 978-81-7637-314-2 [Crossref][PubMed][Google Scholar]

12. Tewari P, Kumari A. Yogaratnakar Part 1. Chaukambha Visvabharati. 2010 ed. Vatarakta Ch. 26/45-48. p. 629. ISBN: 978-81-909871-7-2 [Crossref][PubMed][Google Scholar]

13. Tewari P, Kumari A. Yogaratnakar Part 1. Chaukambha Visvabharati. 2010 ed. Vatarakta Ch. 26/82. p. 633. ISBN: 978-81-909871-7-2 [Crossref][PubMed][Google Scholar]

14. Rao GP, editor. Chakradutta of Cakrapanidatta. Chaukambha Orientalia, Varanasi. 2014 ed. Ch. 23/9. p. 250. ISBN: 978-81-7637-314-2 [Crossref][PubMed][Google Scholar]

15. Netmeds. Health Library. Kaishore Guggulu. . [Crossref][PubMed][Google Scholar]

16. Bhavmisra. Bhavprakash, Vol. 1. Commentary by Sitaram B. Chaukambha Orientalia, Varanasi. Purvakhanda Ch. 6(2) Shlok No. 107-108. p. 151. 2015 ed. ISBN: 978-81-7637-259-6 [Crossref][PubMed][Google Scholar]

17. Ajaya Yerne, Arun Bhatkar, Mrunal R. Akre. Chopchini – A literary review from view of Ayurveda. World Journal Of Pharmaceutical Research. 2019; 8(2): 557-561 [Crossref][PubMed][Google Scholar]


J Ayu Int Med Sci 2025;10(2)357
Neha Y et al. Management of Vata Rakta w.s.r. to Gout

18. Shastri K. Charak Samhita of Agnivesa, revised by Charaka and Drdhabala with Ayurveda-Dipika Commentary. Part 2. 2012 ed. Chaukambha Sanskrit Sansthan, Varanasi. Chikitsa Sthana 29/123. ISBN: 978-81-89798-55-09 [Crossref][PubMed][Google Scholar]

19. Rao GP, editor. Chakradutta of Cakrapanidatta. Chaukambha Orientalia, Varanasi. 2014 ed. Ch. 42/256. p. 250. ISBN: 978-81-7637-314-2 [Crossref][PubMed][Google Scholar]

20. Tewari P, Kumari A. Yogaratnakar Part 1. Chaukambha Visvabharati. 2010 ed. Vatarakta Ch. 26. p. 631. ISBN: 978-81-909871-7-2 [Crossref][PubMed][Google Scholar]

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.


J Ayu Int Med Sci 2025;10(2)358